CON-TGO91-334 - Dr Reddy's Laboratories Australia Pty Ltd
Product names
- AUST R 200933 - CAPECITABINE-DRLA capecitabine 500 mg tablet blister pack
- AUST R 200935 - CAPECITABINE-DRLA capecitabine 150 mg tablet blister pack
Decision Date
Duration
The consent is effective for all batches manufactured between 1 September 2020 and 30 November 2020.
Non-compliance with standard
The product(s) do not conform with the requirements of TGO 91 but are supplied with label(s) that have been approved by the TGA.
Supply/Import or Export
Supply
Therapeutic good type
Prescription medicines